Attached files

file filename
EX-32 - EXHIBIT 32 - NORTECH SYSTEMS INCex_212356.htm
EX-31.2 - EXHIBIT 31.2 - NORTECH SYSTEMS INCex_212355.htm
EX-31.1 - EXHIBIT 31.1 - NORTECH SYSTEMS INCex_212354.htm
EX-10.1 - EXHIBIT 10.1 - NORTECH SYSTEMS INCex_213794.htm
 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

 

FORM 10-Q

 

(Mark One)

 

      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2020

 

OR

 

         TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from            to          

 

NORTECH SYSTEMS INCORPORATED

 

Commission file number 0-13257

 

State of Incorporation: Minnesota

 

IRS Employer Identification No. 41-1681094

 

Executive Offices: 7550 Meridian Circle N., Suite # 150, Maple Grove, MN 55369

 

Telephone number: (952) 345-2244

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $.01 per share

NSYS 

NASDAQ Capital Market 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulations S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer ☐

 

Accelerated Filer ☐

Non-accelerated Filer ☒

Emerging growth company ☐

 

Smaller Reporting Company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐    

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ☐ No ☒

 

Number of shares of $.01 par value common stock outstanding at November 4, 2020 was 2,657,530.

 

 

1

 

 

TABLE OF CONTENTS

 

  PAGE
   
PART I - FINANCIAL INFORMATION  
     

Item 1  -

Financial Statements

 

 

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)

3

 

Condensed Consolidated Balance Sheets

4

 

Condensed Consolidated Statements of Cash Flows

5

 

Condensed Consolidated Statements of Shareholders’ Equity

6

 

Condensed Notes to Consolidated Financial Statements

7-17

Item 2     -

Management's Discussion and Analysis of Financial Condition And Results of Operations

18-25

Item 3     -

Quantitative and Qualitative Disclosures About Market Risk

25

Item 4     -

Controls and Procedures

25

     

PART II - OTHER INFORMATION

 
     

Item 1     -

Legal Proceedings

26
     

Item 1A. -  

Risk Factors

26
     

Item 2     -  

Unregistered Sales of Equity Securities, Use of Proceeds

27
     

Item 3     -   

Defaults on Senior Securities

27
     

Item 4     -  

Mine Safety Disclosures

27
     

Item 5     -  

Other Information

27
     

Item 6    -

Exhibits

27

     

SIGNATURES

 

28

 

2

 

PART

 

ITEM 1. FINANCIAL STATEMENTS

 

 

NORTECH SYSTEMS INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

(UNAUDITED)

(IN THOUSANDS, EXCEPT SHARE DATA)

 

   

THREE MONTHS ENDED

   

NINE MONTHS ENDED

 
   

SEPTEMBER 30,

   

SEPTEMBER 30,

 
   

2020

   

2019

   

2020

   

2019

 
                                 

Net Sales

  $ 26,362     $ 30,058     $ 80,263     $ 85,515  
                                 

Cost of Goods Sold

    24,716       26,423       73,171       76,594  
                                 

Gross Profit

    1,646       3,635       7,092       8,921  
                                 

Operating Expenses

                               

Selling Expenses

    594       589       1,945       2,147  

General and Administrative Expenses

    2,164       2,333       5,819       7,374  

Gain on Sale of Property and Equipment

    (3,821 )     -       (3,821 )     -  

Total Operating Expenses

    (1,063 )     2,922       3,943       9,521  
                                 

Income (Loss) From Operations

    2,709       713       3,149       (600 )
                                 

Other Expense

                               

Interest Expense

    (126 )     (256 )     (526 )     (780 )
                                 

Income (Loss) Before Income Taxes

    2,583       457       2,623       (1,380 )
                                 

Income Tax Expense

    612       44       638       122  
                                 

Net Income (Loss)

  $ 1,971     $ 413     $ 1,985     $ (1,502 )
                                 

Net Income (Loss) Per Common Share:

                               
                                 

Basic (in dollars per share)

  $ 0.74     $ 0.16     $ 0.75     $ (0.56 )

Weighted Average Number of Common Shares Outstanding - Basic (in shares)

    2,657,530       2,657,911       2,657,530       2,667,754  
                                 

Diluted (in dollars per share)

  $ 0.73     $ 0.16     $ 0.74     $ (0.56 )

Weighted Average Number of Common Shares Outstanding - Diluted (in shares)

    2,703,029       2,657,911       2,678,698       2,667,754  
                                 

Other comprehensive income (loss)

                               

Foreign currency translation

    96       (56 )     54       (56 )

Comprehensive income (loss), net of tax

  $ 2,067     $ 357     $ 2,039     $ (1,558 )

 

See Accompanying Condensed Notes to Condensed Consolidated Financial Statements

 

3

 

 

NORTECH SYSTEMS INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS 

(IN THOUSANDS, EXCEPT SHARE DATA)

 

   

SEPTEMBER 30,

   

DECEMBER 31,

 
   

2020

   

2019(1)

 
    (Unaudited)          

ASSETS

 

 

         

Current Assets

               

Cash

  $ 328     $ 351  

Restricted Cash

    1,366       309  

Accounts Receivable, less allowances of $493 and $335

    16,019       18,558  

Inventories

    14,496       14,279  

Contract Assets

    7,334       7,659  

Prepaid Expenses and Other Current Assets

    1,274       2,128  

Total Current Assets

    40,817       43,284  
                 

Property and Equipment, Net

    6,631       9,581  

Operating Lease Assets

    8,924       4,827  

Goodwill

    2,375       2,375  

Other Intangible Assets, Net

    1,210       1,343  

Total Assets

  $ 59,957     $ 61,410  
                 

LIABILITIES AND SHAREHOLDERS' EQUITY

               

Current Liabilities

               

Current Maturities of Long-Term Debt

  $ 444     $ 444  

Current Portion of Finance Lease Obligation

    652       557  

Current Portion of Operating Lease Obligations

    614       858  

Accounts Payable

    11,213       14,014  

Accrued Payroll and Commissions

    2,912       3,493  

Customer Deposits

    631       618  

Income Tax Payable

    398       134  

Other Accrued Liabilities

    1,382       2,114  

Total Current Liabilities

    18,246       22,232  
                 

Long-Term Liabilities

               

Long Term Line of Credit

    2,546       10,088  

Long-Term Debt, Net

    6,730       3,179  

Long Term Finance Lease Obligation, Net

    1,320       1,451  

Long-Term Operating Lease Obligation, Net

    8,832       4,366  

Other Long-Term Liabilities

    157       118  

Total Long-Term Liabilities

    19,585       19,202  

Total Liabilities

    37,831       41,434  
                 

Shareholders' Equity

               

Preferred Stock, $1 par value; 1,000,000 Shares Authorized: 250,000 Shares Issued and Outstanding

    250       250  

Common Stock - $0.01 par value; 9,000,000 Shares Authorized: 2,657,530 Shares Issued and Outstanding

    27       27  

Additional Paid-In Capital

    15,859       15,748  

Accumulated Other Comprehensive Loss

    (203 )     (257 )

Retained Earnings

    6,193       4,208  

Total Shareholders' Equity

    22,126       19,976  

Total Liabilities and Shareholders' Equity

  $ 59,957     $ 61,410  

 

See Accompanying Condensed Notes to Condensed Consolidated Financial Statements

 

(1) The balance sheet at December 31, 2019 has been derived from the audited financial statements at that date

 

4

 

 

NORTECH SYSTEMS INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(IN THOUSANDS)

 

   

NINE MONTHS ENDED

 
   

SEPTEMBER 30,

 
   

2020

   

2019

 

Cash Flows From Operating Activities

               

Net Income (Loss)

  $ 1,985     $ (1,502 )

Adjustments to Reconcile Net Income (Loss) to Net Cash

               

Used In Operating Activities

               

Depreciation and Amortization

    1,703       1,648  

Compensation on Stock-Based & Equity Awards

    151       226  

Deferred Taxes

    -       1  

Change in Accounts Receivable Allowance

    158       101  

Change in Inventory Reserves

    398       285  

Gain on Disposal of Property and Equipment

    (3,821 )     -  

Changes in Current Operating Items

               

Accounts Receivable

    2,430       (158 )

Inventories

    (567 )     (237 )

Contract Assets

    325       (780 )

Prepaid Expenses and Other Current Assets

    858       (641 )

Accounts Payable

    (2,808 )     663  

Accrued Payroll and Commissions

    (621 )     (120 )

Other Accrued Liabilities

    (290 )     281  

Net Cash Used in Operating Activities

    (99 )     (233 )

Cash Flows from Investing Activities

               

Proceeds from Sale of Property and Equipment

    6,019       -  

Purchase of Intangible Asset

    (25 )     (37 )

Purchases of Property and Equipment

    (397 )     (785 )

Net Cash Provided By (Used In) Investing Activities

    5,597       (822 )

Cash Flows from Financing Activities

               

Net Change in Line of Credit

    (7,542 )     3,165  

Proceeds from Long-Term Debt

    6,077       -  

Principal Payments on Long-Term Debt

    (2,567 )     (728 )

Principal Payments on Finance Leases

    (432 )     (251 )

Stock option exercises

    -       7  

Share Repurchases

    -       (130 )

Net Cash (Used In) Provided By Financing Activities

    (4,464 )     2,063  
                 

Effect of Exchange Rate Changes on Cash

    -       (2 )
                 

Net Change in Cash

    1,034       1,006  

Cash - Beginning of Period

    660       948  

Cash - Ending of Period

  $ 1,694     $ 1,954  
                 

Reconciliation of cash and restricted cash reported within the condensed consolidated balance sheets

               

Cash

  $ 328     $ 160  

Restricted Cash

    1,366       1,794  

Total cash and restricted cash reported in the condensed consolidated statements of cash flows

  $ 1,694     $ 1,954  
                 

Supplemental Disclosure of Cash Flow Information:

               

Cash Paid During the Period for Interest

  $ 526     $ 739  

Cash Paid (Refunded) During the Period for Income Taxes

    262       (83 )
                 

Supplemental Noncash Investing and Financing Activities:

               

Property and Equipment Purchases in Accounts Payable

    6       30  

Equipment Acquired under Finance Lease

    395       607  

 

See Accompanying Condensed Notes to Condensed Consolidated Financial Statements

 

5

 

 

NORTECH SYSTEMS INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

(UNAUDITED)

(IN THOUSANDS)

 

                           

Accumulated

           

 

 
                   

Additional

   

Other

   

Retained

    Total  
   

Preferred

   

Common

   

Paid-In

   

Comprehensive

    Income     Shareholders'  
   

Stock

   

Stock

   

Capital

   

Loss

   

Earnings

   

Equity

 
                                                 

BALANCE JUNE 30, 2019

  $ 250     $ 27     $ 15,682     $ (233 )   $ 3,521     $ 19,247  

Net Income

    -       -       -       -       413       413  

Cumulative Adjustment

    -       -       -       -       -       -  

Foreign currency translation adjustment

    -       -       -       (56 )     -       (56 )

Compensation on stock-based awards

    -       -       35       -       -       35  

Share repurchases

    -       -       (4 )     -       -       (4 )
                                                 

BALANCE SEPTEMBER 30, 2019

  $ 250     $ 27     $ 15,713     $ (289 )   $ 3,934     $ 19,635  
                                                 

BALANCE DECEMBER 31, 2018

  $ 250     $ 27     $ 15,610     $ (233 )   $ 5,436     $ 21,090  

Net Income

    -       -       -       -       (1,502 )     (1,502 )

Cumulative Adjustment

    -       -       -       -       -       -  

Foreign currency translation adjustment

    -       -       -       (56 )     -       (56 )

Stock option exercises

    -       -       7       -       -       7  

Compensation on stock-based awards

    -       -       226       -       -       226  

Share repurchases

    -       -       (130 )     -       -       (130 )
                                                 

BALANCE SEPTEMBER 30, 2019

  $ 250     $ 27     $ 15,713     $ (289 )   $ 3,934     $ 19,635  
                                                 
                                                 

BALANCE JUNE 30, 2020

  $ 250     $ 27     $ 15,823     $ (299 )   $ 4,222     $ 20,023  

Net Income

    -       -       -       -       1,971       1,971  

Foreign currency translation adjustment

    -       -       -       96       -       96  

Compensation on stock-based awards

    -       -       36       -       -       36  

Share repurchases

    -       -       -       -       -       -  
                                                 

BALANCE SEPTEMBER 30, 2020

  $ 250     $ 27     $ 15,859     $ (203 )   $ 6,193     $ 22,126  
                                                 

BALANCE DECEMBER 31, 2019

  $ 250     $ 27     $ 15,748     $ (257 )   $ 4,208     $ 19,976  

Net Income

    -       -       -       -       1,985       1,985  

Foreign currency translation adjustment

    -       -       -       54       -       54  

Stock option exercises

    -       -       -       -       -       -  

Compensation on stock-based awards

    -       -       111       -       -       111  

Share repurchases

    -       -       -       -       -       -  
                                                 

BALANCE SEPTEMBER 30, 2020

  $ 250     $ 27     $ 15,859     $ (203 )   $ 6,193     $ 22,126  

 

See Accompanying Condensed Notes to Condensed Consolidated Financial Statements

 

6

 

CONDENSED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(DOLLARS IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)
(UNAUDITED)

 

 

NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements for the interim periods have been prepared in accordance with Generally Accepted Accounting Principles in the United States of America (“GAAP”) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all of the financial information and footnotes required by GAAP for complete financial statements, although we believe the disclosures are adequate to make the information presented not misleading. It is suggested that these condensed consolidated financial statements be read in conjunction with the consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2019. The operating results for the interim periods presented are not necessarily indicative of the results expected for the full year or for any other interim period. In our opinion, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included.

 

The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. In preparing these condensed consolidated financial statements, we have made our best estimates and judgments of certain amounts included in the condensed consolidated financial statements, giving due consideration to materiality. Changes in the estimates and assumptions used by us could have a significant impact on our financial results, since actual results could differ from those estimates.

 

Principles of Consolidation

The condensed consolidated financial statements include the accounts of Nortech Systems Incorporated and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated.

 

Revenue Recognition

Our revenue is comprised of product, engineering services and repair services. All revenue is recognized when the Company satisfies its performance obligation(s) under the contract by transferring the promised product or service to our customer either when (or as) our customer obtains control of the product or service, with the majority of our revenue being recognized over time including goods produced under contract manufacturing agreements and services revenue. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer. A contract’s transaction price is allocated to each distinct performance obligation. The majority of our contracts have a single performance obligation. Revenue is recorded net of returns, allowances and customer discounts. Our net sales for services were less than 10% of our total sales for all periods presented, and accordingly, are included in net sales in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). Sales, value add, and other taxes collected from customers and remitted to governmental authorities are accounted for on a net (excluded from revenues) basis. Shipping and handling costs charged to our customers are included in net sales, while the corresponding shipping expenses are included in cost of goods sold.

 

7

 

Stock-Based Awards

Following is the status of all stock options as of September 30, 2020:

 

   

Shares

   

Weighted-

Average

Exercise

Price Per

Share

   

Weighted-

Average

Remaining

Contractual

Term

(in years)

   

Aggregate

Intrinsic Value
(in thousands)

 

Outstanding - January 1, 2020

    372,200     $ 3.85                  

Granted

    11,300       2.95                  

Exercised

    -                          

Cancelled

    (16,667 )     3.65                  

Outstanding - September 30, 2020

    366,833     $ 3.83       7.88     $ 317  

Exercisable - September 30, 2020

    181,640     $ 3.72       7.44     $ 176  

 

In May 2017, the shareholders approved the 2017 Stock Incentive Plan which has authorized the issuance of 400,000 shares including an additional 50,000 shares authorized in March 2020. There were 11,300 stock options granted during the nine months ended September 30, 2020.

 

Total compensation expense was $36 and $35 for the three months ended September 30, 2020 and 2019, respectively, and $111 and $226 for the nine months ended September 30, 2020 and 2019, respectively. As of September 30, 2020, there was $260 of unrecognized compensation which will vest over the next 2.39 years.

 

In November 2010, the Board of Directors adopted the Nortech Systems Incorporated Equity Appreciation Rights Plan (“2010 Plan”). The total number of Equity Appreciation Right Units (“Units”) that can be issued under the 2010 Plan shall not exceed an aggregate of 1,000,000 Units as amended and restated on March 11, 2015. During the nine months ended September 30, 2019, there were 137,500 Units granted. There were no Units granted during the nine months ended September 30, 2020. Total compensation expense related to the vested outstanding Units based on the estimated appreciation over their remaining terms was approximately $40 for both the three and nine months ended September 30, 2020 and no expense in the three and nine months ended September 30, 2019. The total long-term liability recorded for the Units at September 30, 2020 is $40.

 

 

Net Income (Loss) per Common Share

For the three and nine months ended September 30 ,2020, stock options of 45,326 and 21,110, respectively, were included in the computation of diluted income per common share amount as their impact were dilutive. For both the three months and nine months ended September 30, 2019, all stock options were deemed to be antidilutive and, therefore, were not included in the computation of income per common share amount.

 

8

 

Restricted Cash

Cash and cash equivalents classified as restricted cash on our condensed consolidated balance sheets are restricted as to withdrawal or use under the terms of certain contractual agreements. The September 30, 2020 balance included lockbox deposits that are temporarily restricted due to timing at the period end. The lockbox deposits are applied against our line of credit the next business day. As of September 30, 2020, we had outstanding letters of credit for $500 in total to Essjay Bemidji Holdings, LLC and Essjay Mankato Holdings, LLC.

 

Accounts Receivable and Allowance for Doubtful Accounts

Credit is extended based upon an evaluation of the customer’s financial condition and, while collateral is not required, the Company periodically receives surety bonds that guarantee payment. Credit terms are consistent with industry standards and practices. The amounts of trade accounts receivable have been reduced by an allowance for doubtful accounts of $493 at September 30, 2020 and $335 at December 31, 2019.

 

Inventories

Inventories are stated at the lower of cost (average cost method) or net realizable value. Costs include material, labor, and overhead required in the warehousing and production of our products. Inventory reserves are maintained for the estimated value of the inventories that may have a lower value than stated or quantities in excess of future production needs.

 

Inventories are as follows:

 

   

September 30,

   

December 31,

 
   

2020

   

2019

 

Raw Materials

  $ 15,314     $ 15,245  

Work in Process

    607       479  

Finished Goods

    459       41  

Reserves

    (1,884 )     (1,486 )
                 

Total

  $ 14,496     $ 14,279  

 

Property and Equipment

Property and equipment are stated at cost less accumulated depreciation. Additions, improvements and major renewals are capitalized, while maintenance and minor repairs are expensed as incurred. When assets are retired or disposed of, the assets and related accumulated depreciation are removed from the accounts and the resulting gain or loss is reflected in operations. Leasehold improvements are depreciated over the shorter of their estimated useful lives or their remaining lease terms. All other property and equipment are depreciated by the straight-line method over their estimated useful lives.

 

In the three months ended September 30, 2020, we closed on a sale and leaseback agreement with Essjay Investment Company, LLC (“Essjay”) relating to the Company’s manufacturing facilities in Bemidji and Mankato, Minnesota. The Company received net proceeds from the sale, excluding closing costs, of approximately $6,019 and recorded a gain on sale of property of equipment of $3,821. The Company entered into lease agreements for the Bemidji, Minnesota facility and the Mankato, Minnesota facility for an initial 15-year term, with multiple 5-year renewal options. See disclosure of leases in Note 5, Leases.

 

9

 

Other Intangible Assets

Other intangible assets at September 30, 2020 and December 31, 2019 are as follows:

 

           

September 30, 2020

 
           

Gross

                 
           

Carrying

   

Accumulated

   

Net Book

 
   

Years

   

Amount

   

Amortization

   

Value

 

Customer Relationships

    9     $ 1,302     $ 759     $ 543  

Intellectual Property

    3       100       100       -  

Trade Names

    20       814       214       600  

Patents

    7       67       -       67  

Totals

          $ 2,283     $ 1,073     $ 1,210  

 

           

December 31, 2019

 
           

Gross

                 
           

Carrying

   

Accumulated

   

Net Book

 
   

Years

   

Amount

   

Amortization

   

Value

 

Customer Relationships

    9     $ 1,302     $ 651     $ 651  

Intellectual Property

    3       100       95       5  

Trade Names

    20       814       183       631  

Patents

    7       56       -       56  

Totals

          $ 2,272     $ 929     $ 1,343  

 

Amortization expense for the three and nine months ended September 30, 2020 was $47 and $145 respectively.

 

Estimated future annual amortization expense (not including projects in process) related to these assets is approximately as follows (in thousands):

 

Year

 

Amount

 

Remainder of 2020

  $ 46  

2021

    186  

2022

    185  

2023

    185  

2024

    113  

Thereafter

    428  

Total

  $ 1,143  

 

Impairment of Goodwill and Other Intangible Assets

In accordance with ASC 350, Goodwill and Other Intangible Assets, goodwill is not amortized but is required to be reviewed for impairment at least annually or when events or circumstances indicate that carrying value may exceed fair value. We test impairment annually as of October 1st. No events were identified during the nine months ended September 30, 2020 that would require us to test for impairment. In testing goodwill for impairment, we perform a quantitative impairment test, including computing the fair value of the reporting unit and comparing that value to its carrying value. If the fair value is less than its carrying value, then the goodwill is determined to be impaired. In the event that goodwill is impaired, an impairment charge to earnings would become necessary.

 

10

 

Impairment Analysis

We evaluate long-lived assets, primarily property and equipment and intangible assets, as well as the related depreciation periods, whenever current events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. Recoverability for assets to be held and used is based on our projection of the undiscounted future operating cash flows of the underlying assets. To the extent such projections indicate that future undiscounted cash flows are not sufficient to recover the carrying amounts of related assets, a charge might be required to reduce the carrying amount to equal estimated fair value. No impairment expense was recorded during the three and nine months ended September 30, 2020 and 2019, respectively.

 

Accounting Pronouncements Issued But Not Yet Adopted

In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments - Credit Losses (ASC 326): Measurement of Credit Losses on Financial Instruments,” which amends the guidance on the impairment of financial instruments. The amendments in this update removes the thresholds that entities apply to measure credit losses on financial instruments measured at amortized cost, such as loans, trade receivables, reinsurance recoverables, off-balance-sheet credit exposures, and held-to-maturity securities. Under current U.S. GAAP, entities generally recognize credit losses when it is probable that the loss has been incurred. The guidance removes all current recognition thresholds and introduces the new current expected credit loss (“CECL”) model which will require entities to recognize an allowance for credit losses for the difference between the amortized cost basis of a financial instrument and the amount of amortized cost that an entity expects to collect over the instrument’s contractual life. The new CECL model is based upon expected losses rather than incurred losses. The amendments in this update are effective for periods beginning after December 15, 2022; early adoption is permitted. We are currently evaluating the impact of this guidance on our financial condition and results of operations.

 

 

 

NOTE 2. CONCENTRATION OF CREDIT RISK AND MAJOR CUSTOMERS

 

Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash and accounts receivable. With regard to cash, we maintain our excess cash balances in checking accounts at primarily two financial institutions, one in the United States and one in China. The account in the United States may at times exceed federally insured limits. Of the $1,694 in cash at September 30, 2020, approximately $244 was held at banks located in China. We grant credit to customers in the normal course of business and do not require collateral on our accounts receivable.

 

Our largest customer has two divisions that together accounted for 10% or more of our net sales during the three and nine months ended September 30, 2020 and 2019. One division accounted for approximately 20% and 21% of net sales for the three and nine months ended September 30, 2020, respectively, and approximately 19% and 21% for the three and nine months ended September 30, 2019, respectively. The other division accounted for approximately 3% of net sales for both the three months and nine months ended September 30, 2020, and approximately 3% net sales for the three and nine months ended September 30, 2019. Together they accounted for approximately 23% and 24% of net sales for the three and nine months ended September 30, 2020, respectively, and approximately 22% and 24% of net sales for both the three and nine months ended September 30, 2019, respectively. Accounts receivable from the customer at September 30, 2020 and December 31, 2019 represented approximately 37% and 36% of our total accounts receivable, respectively.

 

11

 

Export sales represented approximately 9% of net sales for both the three months ended September 30, 2020 and 2019. Export sales represented 10% and 15% of net sales for the nine months ended September 30, 2020 and 2019, respectively.

 

 

NOTE 3. REVENUE

 

Revenue recognition

Our revenue is comprised of product, engineering services and repair services. All revenue is recognized when the Company satisfies its performance obligation(s) under the contract by transferring the promised product or service to our customer either when (or as) our customer obtains control of the product or service, with the majority of our revenue being recognized over time including goods produced under contract manufacturing agreements and services revenue. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer. A contract’s transaction price is allocated to each distinct performance obligation. The majority of our contracts have a single performance obligation, as the promise to transfer products or services is not separately identifiable from other promises in the contract and, therefore, not distinct.

 

Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products or providing services. As such, revenue is recorded net of returns, allowances and customer discounts. Sales, value add, and other taxes collected from customers and remitted to governmental authorities are accounted for on a net (excluded from revenues) basis. Shipping and handling costs are included in cost of goods sold.

 

The majority of our revenue is derived from the transfer of goods produced under contract manufacturing agreements which have no alternative use and we have an enforceable right to payment for our performance completed to date. Our performance obligations within our contract manufacturing agreements are generally satisfied over time as the goods are produced based on customer specifications and we have an enforceable right to payment for the goods produced. If these requirements are not met, the revenue is recognized at a point in time, generally upon shipment. Revenue under contract manufacturing agreements that was recognized over time accounted for approximately 80% and 84% of our revenue for the three and nine months ended September 30, 2020, respectively. Revenues under these agreements are generally recognized over time using an input measure based upon the proportion of actual costs incurred.

 

Accounting for contract manufacturing agreements involves the use of various techniques to estimate total revenue and costs. We estimate profit on these agreements as the difference between total estimated revenue and expected costs to complete the performance obligation within the terms of the agreement and recognize the respective profit as the goods are produced. The estimates to determine the profit earned on the performance obligation are based on anticipated selling prices and historical cost of goods sold and represent our best judgement at the time. Changes in judgements on these above estimates could impact the timing and amount of revenue recognized with a resulting impact on the timing and amount of associated profit.

 

On occasion our customers provide materials to be used in the manufacturing process and the fair value of the materials is included in revenue as noncash consideration at the point in time when the manufacturing process commences along with the same corresponding amount recorded as cost of goods sold. The inclusion of noncash consideration has no impact on overall profitability.

 

12

 

Contract Assets

Contract assets, recorded as such in the Condensed Consolidated Balance Sheets, consist of unbilled amounts related to revenue recognized over time. Significant changes in the contract assets balance during the nine months ended September 30, 2020 was as follows:

 

Nine Months Ended September 30, 2020

       

Outstanding at January 1, 2020

  $ 7,659  

Increase (decrease) attributed to:

       

Transferred to receivables from contract assets recognized

    (6,104 )

Product transferred over time

    5,779  

Outstanding at September 30, 2020

  $ 7,334  

 

We expect substantially all the remaining performance obligations for the contract assets recorded as of September 30, 2020, to be transferred to receivables within 90 days, with any remaining amounts to be transferred within 180 days. We bill our customers upon shipment with payment terms of up to 120 days.

 

The following tables summarize our net sales by market for the three and nine months ended September 30, 2020:

 

   

Three Months Ended September 30, 2020

 
   

Product/ Service

Transferred

Over Time

   

Product

Transferred at

Point in Time

   

Noncash

Consideration

   

Total Net Sales

by Market

 

Medical

  $ 10,960     $ 1,853     $ 1,405     $ 14,218  

Industrial

    4,527       791       620       5,938  

Aerospace and Defense

    5,525       16       665       6,206  

Total net sales

  $ 21,012     $ 2,660     $ 2,690     $ 26,362  

 

   

Three Months Ended September 30, 2019

 
   

Product/ Service

Transferred

Over Time

   

Product

Transferred at

Point in Time

   

Noncash

Consideration

   

Total Net Sales

by Market

 

Medical

  $ 14,399     $ 1,661     $ 983     $ 17,043  

Industrial

    7,279       822       522       8,623  

Aerospace and Defense

    3,978       133       281       4,392  

Total net sales

  $ 25,656     $ 2,616     $ 1,786     $ 30,058  

 

13

 

   

Nine Months Ended September 30, 2020

 
   

Product/ Service

Transferred

Over Time

   

Product

Transferred at

Point in Time

   

Noncash

Consideration

   

Total Net Sales

by Market

 

Medical

  $ 35,835     $ 4,454     $ 2,464     $ 42,753  

Industrial

    17,434       3,354       1,213       22,001  

Aerospace and Defense

    14,160       396       953       15,509  

Total net sales

  $ 67,429     $ 8,204     $ 4,630     $ 80,263  

 

   

Nine Months Ended September 30, 2019

 
   

Product/ Service

Transferred

Over Time

   

Product

Transferred at

Point in Time

   

Noncash

Consideration

   

Total Net Sales

by Market

 

Medical

  $ 42,039     $ 1,914     $ 2,053     $ 46,006  

Industrial

    22,847       2,297       1,146       26,290  

Aerospace and Defense

    12,236       375       608       13,219  

Total net sales

  $ 77,122     $ 4,586     $ 3,807     $ 85,515  

 

 

 

NOTE 4. FINANCING ARRANGEMENTS

 

We have a credit agreement with Bank of America which was entered into on June 15, 2017 and amended effective December 29, 2017 and provides for a line of credit arrangement of $16,000 that expires on June 15, 2022. The credit arrangement also has a $5,000 real estate term note outstanding with a maturity date of June 15, 2022.

 

Under the Bank of America credit agreement, both the line of credit and real estate term notes are subject to variations in the LIBOR rate. Our line of credit bears interest at a weighted-average interest rate of 3.7% and 5.4% as of September 30, 2020 and 2019, respectively. We had borrowings on our line of credit of $2,546 and $10,088 outstanding as of September 30, 2020 and December 31, 2019, respectively. There are no subjective acceleration clauses under the credit agreement that would accelerate the maturity of our outstanding borrowings.

 

The line of credit and real estate term notes with Bank of America contain certain covenants which, among other things, require us to adhere to regular reporting requirements, abide by annual shareholder dividend limitations, maintain certain financial performance, and limit the amount of annual capital expenditures. The availability under our line is subject to borrowing base requirements, and advances are at the discretion of the lender. The line of credit is secured by substantially all of our assets. At September 30, 2020, we had unused availability under our line of credit of $8,640, supported by our borrowing base.

 

The Bank of America Credit Agreement provides for, among other things, a Fixed Charge Coverage Ratio of not less than (i) 1.0 to 1.0, for the three months ending December 31, 2019, six months ending March 31, 2020, nine months ending June 30, 2020 and twelve months ending September 30, 2020 and each Fiscal Quarter end thereafter. The Company met the covenants for the period ended September 30, 2020.

 

14

 

On April 15, 2020, we entered into a Promissory Note with Bank of America, N.A. (the “Promissory Note”), which provides for an unsecured loan of $6,077 pursuant to the Paycheck Protection Program under the Coronavirus Aid, Relief, and Economic Security Act and applicable regulations (the “CARES Act”) of which funds were received on April 22, 2020. The Promissory Note has a term of 2 years with a 1% per annum interest rate. Payments are deferred for 10 months after the end of the Promissory Note covered period (which is defined as 24 weeks after the date of the loan) and we can apply for forgiveness of the Promissory Note after 60 days. Forgiveness of the Promissory Note will be determined in accordance with the provisions of the Cares Act and applicable regulations. Any principal and interest amounts outstanding after the determination of amounts forgiven will be repaid on a monthly basis.

 

Long-term debt at September 30, 2020 and December 30, 2019 consisted of following:

 

   

September 30,

   

December 31,

 
   

2020

   

2019

 

Real estate term notes bearing interest at one-month LIBOR + 2.25% (3.0% and 4.1% as of September 30, 2020 and December 31, 2019, respectively) maturing June 15, 2022 with monthly payments of approximately $41 plus interest secured by substantially all assets.

  $ 1,188     $ 3,755  
                 

Promissory Note

    6,077       -  
                 
      7,265       3,755  
                 

Debt issuance Costs

    (91 )     (132 )
                 

Total long-term debt

    7,174       3,623  

Current maturities of long-term debt

    (444 )     (444 )

Long-term debt - net of current maturities

  $ 6,730     $ 3,179  

 

 

 

NOTE 5. LEASES

 

We have operating leases for certain manufacturing sites, office space, and equipment. Most leases include the option to renew, with renewal terms that can extend the lease term from one to five years or more. Right-of-use lease assets and lease liabilities are recognized at the commencement date based on the present value of the remaining lease payments over the lease term which includes renewal periods we are reasonably certain to exercise. Our leases do not contain any material residual value guarantees or material restrictive covenants. At September 30, 2020, we do not have material lease commitments that have not commenced.

 

15

 

Supplemental balance sheet information related to leases was as follows:

 

 

Balance Sheet Location

 

September 30, 2020

 

Assets

         

Operating lease assets

Operating lease assets

  $ 8,924  

Finance lease assets

Property, Plant and Equipment

    2,493  

Total leased assets

  $ 11,417  
           

Liabilities

         

Current

         

Current operating lease liabilities

Current Portion of Operating Lease Obligations

  $ 614  

Current finance lease liabilities

Current Portion of Finance Lease Obligations

    652  

Noncurrent

         

Long-term operating lease liabilities

Long Term Operating Lease Liabilities, Net

    8,832  

Long term finance lease liabilities

Long Term Finance Lease Obligations, Net

    1,320  

Total lease liabilities

  $ 11,418  

 

Supplemental cash flow information related to leases was as follows:

 

   

Nine Months Ended September 30,

 
   

2020

 

Operating leases

       

Cash paid for amounts included in the measurement of lease liabilities

  $ 686  

Right-of-use assets obtained in exchange for lease obligations

  $ 4,685  

 

Maturities of lease liabilities were as follows:

 

   

Operating

Leases

   

Finance Leases

   

Total

 

Remaining 2020

  $ 351     $ 207     $ 558  

2021

    1,264       738       2,002  

2022

    1,279       575       1,854  

2023

    1,302       333       1,635  

2024

    1,374       277       1,651  

Thereafter

    9,489       20       9,509  

Total lease payments

  $ 15,059     $ 2,150     $ 17,209  

Less: Interest

    (5,613

)

    (178 )     (5,791

)

Present value of lease liabilities

  $ 9,446     $ 1,972     $ 11,418  

 

The lease term and discount rate at September 30, 2020 were as follows:

 

Weighted-average remaining lease term (years)

       

Operating leases

    11.1  

Finance leases

    3.3  

Weighted-average discount rate

       

Operating leases

    7.4

%

Finance leases

    5.2

%

 

16

 

 

NOTE 6. INCOME TAXES

 

On a quarterly basis, we estimate what our effective tax rate will be for the full fiscal year and record a quarterly income tax provision based on the anticipated rate. As the year progresses, we refine our estimate based on the facts and circumstances, including discrete events, by each tax jurisdiction. Our effective tax rate for the three and nine months ended September 30, 2020 was 24% and our effective tax rate for the three and nine months ended September 30, 2019 was 10% and (9%), respectively.

 

 

NOTE 7. RELATED PARTY TRANSACTIONS

 

During three and nine months ended September 30, 2020, we did business with Printed Circuits, Inc. which is 90% owned by the Kunin family, of which, owns a majority of our stock. We had expenses incurred totaling $0 and $35 during the three months ended September 30, 2020 and 2019, and $28 and $87 for the nine months ended September 30, 2020 and 2019, respectively to Printed Circuits, Inc.

 

17

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Overview

 

We are a Maple Grove, Minnesota based full-service electronics manufacturing services (“EMS”) contract manufacturer of wire and cable assemblies, printed circuit board assemblies, higher-level assemblies and box builds for a wide range of industries. We provide value added engineering services and technical support including design, testing, prototyping and supply chain management to customers mainly in the aerospace and defense, medical, and industrial equipment markets. We maintain facilities in Bemidji, Blue Earth, Mankato, Maple Grove, Merrifield, and Milaca, Minnesota; Monterrey, Mexico; and Suzhou, China. All of our facilities are certified to one or more of the ISO/AS standards, including 9001, AS9100 and 13485, with most having additional certifications based on the needs of the customers they serve.

 

Recent Developments

 

Global Pandemic

In March 2020, the World Health Organization recognized the outbreak of a novel coronavirus (“COVID-19”) as a pandemic. While the COVID-19 pandemic has had an impact on our operations, we have been able to continue to operate our manufacturing facilities and provide essential services to our customers. Additionally, in an effort to protect the health and safety of our employees and in compliance with state regulations, we have instituted a work-from-home policy for employees who can perform their job functions offsite, implemented social distancing requirements and other measures to allow manufacturing and other personnel essential to production to continue work within our manufacturing facilities, and suspended all non-essential employee travel.

 

The full extent to which COVID-19 will directly or indirectly impact our business, financial condition, and results of operations will depend on future developments that are highly uncertain and cannot be accurately predicted, including new information that may emerge concerning COVID-19, the actions taken to contain it or treat its impact and the economic impact on local, regional, national and international markets. We will continue to assess the potential impact of the COVID-19 pandemic on our business, financial condition, and results of operations.

 

We continue to actively manage our cash and working capital to preserve adequate liquidity and ensure that our business can continue to operate during these uncertain times. 

 

Facility Consolidation 

To further improve operational efficiencies and lower overhead costs, the Company approved on August 7, 2020, the closure of our Merrifield, Minnesota, production facility, shifting wire and cable assembly, system-level assembly and printed circuit board (PCB) manufacturing to Nortech’s other Minnesota locations. The Merrifield production facility consolidation is expected to be complete on or before December 31, 2020, and will impact approximately 60 employees, who will be offered positions at other Nortech facilities in Minnesota. As of September 30, 2020, this closure did not qualify for held for sale nor discontinued operations accounting.

 

18

 

Results of Operations

 

The following table presents statements of operations data as percentages of total net sales for the periods indicated:

 

   

Three Months Ended

   

Nine Months Ended

 
   

September 30,

   

September 30,

 
   

2020

   

2019

   

2020

   

2019

 

Net Sales

    100.0

%

    100.0

%

    100.0

%

    100.0

%

Cost of Goods Sold

    93.8       87.9       91.2       89.6  

Gross Profit

    6.2       12.1       8.8       10.4  
                                 

Selling Expenses

    2.3       2.0       2.4       2.5  

General and Administrative Expenses

    8.2       7.7       7.2       8.6  

Gain on Sale of Property and Equipment

    (14.5 )     0.0       (4.8 )     0.0  

Income (Loss) from Operations

    10.2       2.4       4.0       (0.7 )
                                 

Other Expenses

    (0.5 )     (0.9 )     (0.7 )     (0.9 )

Income (Loss) Before Income Taxes

    9.7       1.5       3.3       (1.6 )
                                 

Income Tax Expense

    2.3       0.1       0.8       0.2  

Net Income (Loss)

    7.4

%

    1.4

%

    2.5

%

    (1.8

)%

 

Net Sales

 

Net sales were $26.4 million in the third quarter of 2020, as compared to $30.1 million in the third quarter of the prior year, a decrease of $3.7 million or 12.3% that was driven in part by the COVID-19 pandemic. Net sales results were varied by markets; the medical market decreased by $2.8 million or 16.6% with medical devices accounting for the largest portion of the decrease. The industrial market decreased by $2.7 million or 31.1% of sales in the third quarter of 2020 as compared to the same quarter of 2019. Net sales from the aerospace and defense markets increased by $1.8 million or 41.3% of sales in the third quarter of 2020 as compared to the third quarter of 2019.

 

Net sales were $80.3 million in the nine months ended 2020, as compared to $85.5 million in the prior year, a decrease of $5.3 million or 6.1% that was driven in part by the COVID-19 pandemic. Net sales results were varied by markets; the medical market decreased by $3.3 million, or 7.1% with medical device accounting for 45.6% of the decrease and medical component products the remaining 54.4%. The industrial market decreased by $4.3 million of sales or 16.3% for the nine months ended September 30, 2020 as compared to the same period of 2019. Net sales from aerospace and defense markets increased by $2.3 million of sales or 17.3% for the nine months ended September 30, 2020 as compared to the same period of 2019.

 

19

 

Net sales by our major EMS industry markets for the three and nine months ended September 30, 2020 and 2019 were as follows (in thousands):

 

   

Three months Ended September 30,

   

Nine Months Ended September 30,

 
   

2020

   

2019

   

%

   

2020

   

2019

   

%

 
   

$

   

$

   

Change

   

$

   

$

   

Change

 

Medical

    14,218       17,043       (16.6 )     42,753       46,006       (7.1 )

Industrial

    5,938       8,623       (31.1 )     22,001       26,290       (16.3 )

Aerospace and Defense

    6,206       4,392       41.3       15,509       13,219       17.3  

Total Net Sales

    26,362       30,058       (12.3 )     80,263       85,515       (6.1 )

 

Net sales by timing of transfer of goods and services for the three and nine months ended September 30, 2020 is as follows (in thousands):

 

   

Three Months Ended September 30, 2020

 
   

Product/ Service

Transferred

Over Time

   

Product

Transferred at

Point in Time

   

Noncash

Consideration

   

Total Net Sales

by Market

 

Medical

  $ 10,960     $ 1,853     $ 1,405     $ 14,218  

Industrial

    4,527       791       620       5,938  

Aerospace and Defense

    5,525       16       665       6,206  

Total net sales

  $ 21,012     $ 2,660     $ 2,690     $ 26,362  

 

   

Nine Months Ended September 30, 2020

 
   

Product/ Service

Transferred

Over Time

   

Product

Transferred at

Point in Time

   

Noncash Consideration

   

Total Net Sales

by Market

 

Medical

  $ 35,835     $ 4,454     $ 2,464     $ 42,753  

Industrial

    17,434       3,354       1,213       22,001  

Aerospace and Defense

    14,160       396       953       15,509  

Total net sales

  $ 67,429     $ 8,204     $ 4,630     $ 80,263  

 

20

 

Net sales by timing of transfer of goods and services for the three and nine months ended September 30, 2019 is as follows (in thousands):

 

   

Three Months Ended September 30, 2019

 
   

Product/ Service

Transferred

Over Time

   

Product

Transferred at

Point in Time

   

Noncash

Consideration

   

Total Net Sales

by Market

 

Medical

  $ 14,399     $ 1,661     $ 983     $ 17,043  

Industrial

    7,279       822       522       8,623  

Aerospace and Defense

    3,978       133       281       4,392  

Total net sales

  $ 25,656     $ 2,616     $ 1,786     $ 30,058  

 

   

Nine Months Ended September 30, 2019

 
   

Product/ Service

Transferred

Over Time

   

Product

Transferred at

Point in Time

   

Noncash

Consideration

   

Total Net Sales

by Market

 

Medical

  $ 42,039     $ 1,914     $ 2,053     $ 46,006  

Industrial

    22,847       2,297       1,146       26,290  

Aerospace and Defense

    12,236       375       608       13,219  

Total net sales

  $ 77,122     $ 4,586     $ 3,807     $ 85,515  

 

Backlog

 

Our 90-day shipment backlog as of September 30, 2020 was $23 million, a 0.8% decrease from the beginning of the quarter and a 27.8% decrease from the prior year. Backlog for our medical customers has decreased 4.2% from the beginning of the quarter and decreased 35.4% from the prior year. Our industrial customers’ backlog increased 10.4% from the beginning of the quarter and decreased 41.7% from the prior year. The aerospace and defense backlog decreased 2.0% from the beginning of the quarter and increased 14.5% from the prior year. Our backlog consists of firm purchase orders we expect to ship in the next 90 days, with any remaining amounts to be transferred within 180 days.

 

90-day shipment backlog by our major EMS industry markets are as follows (in thousands):

 

   

Shipment Backlog as of the Period Ended

 
   

September 30,

   

June 30,

   

September 30,

 
   

2020

   

2020

   

2019

 

Medical

  $ 11,484     $ 11,987     $ 17,778  

Industrial

    4,860       4,401       8,334  

Aerospace and Defense

    6,764       6,900       5,909  

Total 90-Day Backlog

  $ 23,108     $ 23,288     $ 32,021  

 

21

 

Our 90-day backlog varies due to order size, manufacturing delays, contract terms and conditions and timing from customer delivery schedules and releases. These variables cause inconsistencies in comparing the backlog from one period to the next. Our total shipment backlog was $45.7 million at September 30, 2020 compared to $58.1 million at the end of September 30, 2019. This decrease was driven in part to the impact of COVID-19.

 

Gross Profit

 

Gross profit as a percent of net sales for the three months ended September 30, 2020 and 2019 was 6.2% and 12.1%, respectively. Gross profit as a percentage of sales for the nine months ended September 30, 2020 and 2019 was 8.8% and 10.4%, respectively. The decrease in both comparisons was driven by lower sales on a fixed cost base in part due to the impact of COVID-19 and increased inventory reserves.

 

Selling Expense

 

Selling expenses for the three months ended September 30, 2020 and 2019 was $0.6 million or 2.3% of sales and $0.6 million or 2.0% of sales, respectively. Selling expense for the nine months ended September 30, 2020 and 2019 was $1.9 million or 2.4% of sales and $2.1 million or 2.5% of sales, respectively.

 

General and Administrative Expense

 

General and administrative expenses for the three months ended September 30, 2020 and 2019 were $2.2 million or 8.2% of sales and $2.3 million or 7.7% of sales, respectively. General and administrative expenses for the nine months ended September 30, 2020 and 2019 were $5.8 million or 7.2% of sales and $7.4 million or 8.6% of sales, respectively. The decrease in the year to date comparison was due to higher spend in the prior year related one-time expenditures to improve operations in 2019 and the benefits of those cost reduction measures in 2020.

 

Gain on Sale of Property and Equipment

 

The gain on sale of property and equipment was $3.8 million in the three and nine months ended September 30, 2020. This gain was due to the sale leaseback transaction we completed in the period relating to the manufacturing facilities in Bemidji and Mankato, Minnesota.

 

Income (Loss) from Operations

 

Third quarter 2020 income from operations was $2.7 million compared to $0.7 million for the third quarter in 2019. Income from operations for the first nine months in 2020 was $3.1 million as compared to a loss of $0.6 million for the same comparable period in 2019.  The increase in the income from operations in both comparisons was due to the gain on sale of property and equipment of $3.8 million partially offset by lower gross profit.

 

Income Taxes

 

On a quarterly basis, we estimate what our effective tax rate will be for the full fiscal year and record a quarterly income tax provision based on the anticipated rate. As the year progresses, we refine our estimate based on the facts and circumstances, including discrete events, by each tax jurisdiction. Our effective tax rate for the three and nine months ended September 30, 2020 was 24% and our effective tax rate for the three and nine months ended September 30, 2019 was 10% and (9%), respectively.

 

22

 

Net Income (Loss)

 

Net income for the three months ended September 30, 2020 and September 30, 2019 was $2.0 and $0.4 million, respectively. Net income for the nine months ended September 30, 2020 was $2.0 million and net loss for the nine months ended September 30, 2019 was $1.5 million.

 

Liquidity and Capital Resources

 

Our third quarter sales and shipment backlog were impacted by the COVID-19 pandemic. However, our focus on reducing costs, minimizing capital expenditures, and managing working capital mitigated the impact on liquidity. Due to the inherent uncertainty of this evolving situation, we are unable at this time to predict the likely impact of the COVID-19 pandemic on our future operations. However, we believe that cash provided by operations, funds available under the credit agreement with Bank of America, N.A. (BofA), funds available under a Promissory Note with BofA (“Promissory Note”) pursuant to the Paycheck Protection Program under the Coronavirus Aid, funds received from our sales leaseback transaction and cash on hand will be adequate to meet our liquidity needs, including working capital, capital expenditures, and debt payment obligations.

 

Net cash used in operating activities for the nine months ended September 30, 2020 and September 30, 2019 was $0.1 million and $0.2 million, respectively.

 

We have satisfied our liquidity needs over the past several years with cash flows generated from operations and a bank operating line of credit. We have a credit agreement with Bank of America (BofA) which was entered into on June 15, 2017 and amended on December 29, 2017 and provides for a line of credit arrangement of $16.0 million that expires on June 15, 2022. The credit arrangement also has a $5.0 million real estate term note outstanding with a maturity date of June 15, 2022.

 

Both the line of credit and real estate term notes are subject to fluctuations in the LIBOR rates. The line of credit and real estate term notes with BofA contain certain covenants which, among other things, require us to adhere to regular reporting requirements, abide by annual shareholder dividend limitations, maintain certain financial performance, and limit the amount of annual capital expenditures. The availability under our line is subject to borrowing base requirements, and advances are at the discretion of the lender. The line of credit is secured by substantially all of our assets.

 

On September 30, 2020, we had outstanding advances of $2.5 million under the line of credit and unused availability of $8.6 million supported by our borrowing base. We believe our financing arrangements and cash flows to be provided by operations will be sufficient to satisfy our future working capital needs. Our working capital was $22.6 million and $21.1 million as of September 30, 2020 and December 31, 2019, respectively.

 

The Bank of America Credit Agreement provides for, among other things, a Fixed Charge Coverage Ratio of not less than (i) 1.0 to 1.0 for the three months ending December 31, 2019, six months ending March 31, 2020, nine months ending June 30, 2020 and twelve months ending September 30, 2020 and each fiscal quarter end thereafter. The Company met the covenants for the nine months ended September 30, 2020.

 

On April 15, 2020, we entered into a Promissory Note, which provides for an unsecured loan of $6.1 million pursuant to the Paycheck Protection Program under the Coronavirus Aid, Relief, and Economic Security Act and applicable regulations (the “CARES Act”) of which funds were received on April 22, 2020. The Promissory Note has a term of 2 years with a 1% per annum interest rate. Payments are deferred for 10 months after the end of the Promissory Note covered period (which is defined as 24 weeks after the date of the loan) and we can apply for forgiveness of the Promissory Note after 60 days. Forgiveness of the Promissory Note will be determined in accordance with the provisions of the Cares Act and applicable regulations. Any principal and interest amount outstanding after the determination of amounts forgiven will be repaid on a monthly basis. We expect that all or a significant portion of the Promissory Note will be forgiven.

 

23

 

Off-Balance Sheet Arrangements

 

We have not engaged in any off-balance sheet activities as defined in Item 303(a)(4) of Regulation S-K.

 

Critical Accounting Policies and Estimates

 

Our significant accounting policies and estimates are summarized in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2019. Some of our accounting policies require us to exercise significant judgment in selecting the appropriate assumptions for calculating financial estimates. Such judgments are subject to an inherent degree of uncertainty. These judgments are based on our historical experience, known trends in our industry, terms of existing contracts and other information from outside sources, as appropriate. Actual results could differ from these estimates.

 

Forward-Looking Statements

 

Those statements in the foregoing report that are not historical facts are forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995.

 

 

Volatility in the marketplace which may affect market supply, demand of our products or currency exchange rates;

 

Increased competition from within the EMS industry or the decision of OEMs to cease or limit outsourcing;

 

Changes in the reliability and efficiency of our operating facilities or those of third parties;

 

Risks related to availability of labor;

 

Increases in certain raw material costs such as copper and oil;

 

Commodity and energy cost instability;

 

Risks related to FDA noncompliance;

 

The loss of a major customer;

 

General economic, financial and business conditions that could affect our financial condition and results of operations;

 

Increased or unanticipated costs related to compliance with securities and environmental regulation;

 

Disruption of global or local information management systems due to natural disaster or cyber-security incident;

 

Outbreaks of epidemic, pandemic, or contagious diseases, such as the recent novel coronavirus that affect our operations, our customers' operations or our suppliers' operations.

 

The factors identified above are believed to be important factors (but not necessarily all of the important factors) that could cause actual results to differ materially from those expressed in any forward-looking statement made by us. Discussion of these factors is also incorporated in Part I, Item 1A, “Risk Factors,” and should be considered an integral part of Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Unpredictable or unknown factors not discussed herein could also have material adverse effects on forward-looking statements. All forward-looking statements included in this Form 10-Q are expressly qualified in their entirety by the forgoing cautionary statements. We undertake no obligations to update publicly any forward-looking statement (or its associated cautionary language) whether as a result of new information or future events.

 

24

 

Please refer to forward-looking statements and risks as previously disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019, and the risks set forth in PART II, ITEM 1A below.

 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

In accordance with Rule 13a-15(b) of the Securities Exchange Act of 1934 (the “Exchange Act”), as of the end of the period covered by this Quarterly Report on Form 10-Q, our management evaluated, with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act). These controls and procedures are designed to ensure that information required to be disclosed in the Company’s Exchange Act reports is (1) recorded, processed, summarized and reported in a timely manner, and (2) accumulated and communicated to management, including the Company’s Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Based upon their evaluation of these disclosure controls and procedures as of the date of the evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the disclosure controls and procedures were effective.

 

Changes in Internal Control Over Financial Reporting

 

Except for the implementation of certain internal controls related to the adoption of the new lease standard (ASC 842), there was no change in our internal control over financial reporting during our most recently completed fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. 

 

25

 

PART II

 

 

ITEM 1. LEGAL PROCEEDINGS

 

We are subject to various legal proceedings and claims that arise in the ordinary course of business.

 

ITEM 1A. RISK FACTORS

 

We are affected by the risks specific to us as well as factors that affect all businesses operating in a global market. The significant factors known to us that could materially adversely affect our business, financial condition or operating results or could cause our actual results to differ materially from our expectations are described in our annual report on Form 10-K for the fiscal year ended under the heading “Part I – Item 1A.Risk Factors.” Other than as noted below, there have been no material changes in the risk factors from those disclosed in the Annual Report on Form 10-K for the year ended December 31, 2019.

 

Pandemics or disease outbreaks such as the current novel coronavirus (COVID-19 virus) pandemic have affected and is expected to continue to affect adversely our operations, supply chains, financial condition and results of operations.

 

The coronavirus (COVID-19) pandemic is adversely affecting, and is expected to continue to affect adversely, our operations, supply chains, financial condition and results of operations, and we have experienced and expect to continue to experience unpredictable reductions in demand for certain of our services. During the current COVID-19 pandemic, the Company has experienced reduced sales, supply chain disruption, reduced customer demand and reduced availability of workforce.

 

Outbreaks of epidemic, pandemic, or contagious diseases, such as, historically, the Ebola virus, Middle East Respiratory Syndrome, Severe Acute Respiratory Syndrome, or the H1N1 virus, could cause a disruption to our business. Business disruptions could include temporary closures of our facilities or the facilities of our suppliers, reduced demand from customers, unavailability or restricted availability of our material portions of our workforce, raw materials or components necessary to manufacture our products, or disruptions or restrictions on our ability to travel or to distribute our products. Any disruption of our operations, our suppliers or our customers would likely impact our sales and operating results. In addition, a significant outbreak of epidemic, pandemic, or contagious diseases in the human population could result in a widespread health crisis that could adversely affect the economies and financial markets of many countries, resulting in an economic downturn that could affect demand for our products and services. Any of these events could negatively impact our sales and have a material adverse effect on our business, financial condition, results of operations, or cash flows.

 

We may be subject to additional regulatory scrutiny in the form of an audit or review as a result of our Paycheck Protection Program Promissory Note which would have an adverse effect on our liquidity.

 

On April 15, 2020, we entered into a Promissory Note with Bank of America, N.A. (the “Promissory Note”), which provides for an unsecured loan of $6.1 million pursuant to the Paycheck Protection Program (“PPP”) under the Coronavirus Aid, Relief, and Economic Security Act and applicable regulations (the “CARES Act”) of which; funds were received on April 22, 2020. On April 23, 2020, the Small Business Administration (“SBA”) issued new guidance that questioned whether a public company with substantial market value and access to capital markets would qualify to participate in the PPP under the CARES Act. Subsequently, on April 28, 2020, the secretary of the Treasury and SBA announced that the government will review all PPP loans of more than $2 million for which a borrower applies for forgiveness. Should we be audited or reviewed by the U.S. Department of Treasury as a result of filing an application for forgiveness or otherwise, such audit or review could result in legal and reputational costs as well as significant use of management time. While the Company believes that it acted in good faith and has complied with all requirements of the PPP, if we are audited and receive an adverse or negative finding in such audit, we could be required to return up to the full amount of the Promissory Note, which would reduce our liquidity by such amount and potentially subject us to fines and penalties.

 

26

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

As of September 30, 2020, our share repurchase program has expired, and no additional amounts are available for repurchase.

 

ITEM 3. DEFAULTS ON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

None.

 

 

ITEM 6. EXHIBITS

 

Exhibits

 

 

10.1*

Third Quarter 2020 Earnings Release

 

 

31.1*

Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), promulgated under the Securities Exchange Act of 1934, as amended.

 

 

31.2*

Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), promulgated under the Securities Exchange Act of 1934, as amended.

 

 

32*

Certification of the Chief Executive Officer and Chief Financial Officer, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

101*

Financial statements from the quarterly report on Form 10-Q for the quarter ended September 30, 2020, formatted in XBRL: (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Operations and Comprehensive Loss, (iii) Condensed Consolidated Statements of Cash Flows, and (iv) the Condensed Notes to Condensed Consolidated Financial Statements.

 

 

*Filed herewith

 

27

 

Signatures

-------------

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

Nortech Systems Incorporated and Subsidiaries

---------------------------------------------------------

 

 

 

 

 Date: November 12, 2020   

by /s/ Jay D. Miller

 

       

 

Jay D. Miller

Chief Executive Officer and President

Nortech Systems Incorporated

 

 

 

 

 

Date: November 12, 2020 by /s/ Christopher D. Jones  
       
 

Christopher D. Jones

Sr. Vice President and Chief Financial Officer

Nortech Systems Incorporated

 

 

28